HNO 2001-12-01

[Anticholinergic syndrome after postoperative dimenhydrinate administration].

F Matschiner, A Berghaus, A Kober, H Henschel, S Kluge

Index: HNO 49(12) , 1026-8, (2001)

Full Text: HTML

Abstract

Appearance of an anticholinergic syndrome after treatment with drugs in therapeutic dosages is seldom reported in the literature. Based on a case report, the development and course of an anticholinergic syndrome after treatment with dimenhydrinate are described. The drug was given due to different symptoms such as vertigo and vomiting after surgery. The anticholinergic syndrome could successfully be treated with physostigmine.


Related Compounds

Related Articles:

Possible interaction of cholinergic and GABAergic systems between MS and CA1 upon memory acquisition in rats.

2012-12-01

[Behav. Brain Res. 235(2) , 231-43, (2012)]

The effects of physostigmine infusion on patients with panic disorder.

1991-04-01

[Biol. Psychiatry 29(7) , 658-64, (1991)]

Development and optimization of a sublingual tablet formulation for physostigmine salicylate.

2009-09-01

[Acta. Pharm. 59(3) , 301-12, (2009)]

Liquid chromatographic analysis of physostigmine salicylate and its degradation products.

1999-01-01

[J. Pharm. Biomed. Anal. 18(6) , 939-45, (1999)]

Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats.

1988-04-26

[Brain Res. 447(1) , 122-32, (1988)]

More Articles...